Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

OTHER 16 NIH 3 INDUSTRY 2 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 45 Neoplasms 27 Uterine Cervical Neoplasms 24 Prostatic Neoplasms 21 Carcinoma, Non-Small-Cell Lung 20 Colorectal Neoplasms 19 Stomach Neoplasms 18 Carcinoma, Hepatocellular 16 Multiple Myeloma 14 Ovarian Neoplasms 11 Recurrence 10 Pancreatic Neoplasms 10 Esophageal Squamous Cell Carcinoma 10 Esophageal Neoplasms 9 Leukemia, Myeloid, Acute 8 Endometrial Neoplasms 8 Lymphoma 7 Lung Neoplasms 7 Brain Neoplasms 7 Liver Neoplasms 6 Leukemia 6 Disease 6 Carcinoma, Ovarian Epithelial 6 Triple Negative Breast Neoplasms 5 Small Cell Lung Carcinoma 5 Rectal Neoplasms 5 Papillomavirus Infections 5 Colonic Neoplasms 5 Urinary Bladder Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4

Interventions

pembrolizumab 1 lenvatinib 1 Paclitaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER_GOV × Thymoma × Clear all

NCT05832827 2023-10-23

Artemis

National Cancer Center, Japan

Phase 2 Recruiting

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡